Supplement encyclopedia

Vitamin B6

Vitamin B6 is a group of related vitamers obtained from food and found in supplements.

Double-check the conclusions and read the sources before choosing a supplement.

Main conclusion

What it may offer

  • For premenstrual symptoms, 50 mg pyridoxine daily may ease emotional symptoms: in women who completed the study, these were milder than with placebo.
  • In pregnant women before 17 weeks, 30 mg pyridoxine daily for five days reduced nausea by 0.9 points out of 10 more than placebo: the difference was small.
  • Vomiting results in pregnancy differed: 30 mg pyridoxine daily for five days showed no convincing advantage over placebo, while in a smaller study vomiting was less frequent after three days at 75 mg daily.
  • In the anxiety study, 100 mg pyridoxine daily for about a month showed no convincing advantage over placebo in total anxiety score.
  • In adults with stress and low magnesium, adding 30 mg B6 to 300 mg magnesium daily for eight weeks showed no convincing advantage in the whole group. In the high-stress subgroup, the combination reduced stress score by 3.16 points more than magnesium alone.

[1] [2] [3] [4] [5] [6]

What was studied

  • Four studies assessed emotional premenstrual symptoms, nausea and vomiting in pregnancy, and anxiety in young people.
  • The fifth study compared 300 mg magnesium plus 30 mg B6 with the same magnesium intake without B6 in adults with stress and low magnesium.

[1] [2] [3] [4] [5]

Which forms were considered

  • Premenstrual-symptom and anxiety studies used oral pyridoxine; pregnancy-nausea studies used pyridoxine hydrochloride.
  • The stress study used pyridoxine with magnesium: distinguish this combination from B6 alone when choosing a supplement.

[1] [2] [3] [4]

How to get it from food

  • Vitamin B6 can come from fish, meat, poultry, legumes and some fruit; some cereal products are fortified, so check the label.
  • For portion comparison: 85 g yellowfin tuna cooked with dry heat contains about 0.88 mg B6, while 100 g raw banana contains about 0.37 mg.

[1] [2] [3]

Effects and studied questions

How to read the certainty scale 1–4

Certainty is rated separately for each outcome. 1 is very low, 2 is low, 3 is moderate and 4 is high.

Goal or questionResultConfidenceStudiesPopulation studiedKey sources
Emotional PMS symptomsFor PMS, in 32 women who completed the crossover study, emotional symptoms with 50 mg pyridoxine daily were 2.97 study-scale points lower than with placebo after adjustment for phase (p<0.05).2.97 points (SE 1.37), p<0.05; 32 completers
2/4 LowConfidence is low: a randomised trial exists for the exact comparison. Double-blind crossover RCT; 32 of 63 completed it, only 5 dropouts replied to the letter, and completers had more pronounced symptoms than those who completed 4–6 months. The substantial, potentially non-random loss creates serious uncertainty; the authors accounted for phase and for 5 partial completers separately. Only 32 completers, difference 2.97 with SE 1.37 on a 0–63 range; the relatively large error compared with the estimate leaves uncertainty about direction and magnitude on replication. The original CI was not provided; the clinical significance of the magnitude is unknown. Independent replication of this exact outcome has not been established; publication bias remains unknown. This is an assessment of confidence in the comparative result, not of clinical significance or safety.
11 trialPyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial ↗Women aged 18–49 with moderate or marked premenstrual symptoms; 63 enrolled, 32 completed
  1. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial ↗
Total anxiety scoreIn the high-dose B6 study, change in total anxiety score after about a month did not differ convincingly from placebo: time×group interaction p=0.140.SCAARED: 24.8→21.5 versus 25.1→23.9; interaction p=0.140
2/4 LowConfidence is low: a randomised trial exists for the exact comparison. Bottles were randomised by computer; they concealed the tablets, but the tablets differed in appearance. For a subjective outcome, possible unblinding and exclusions based on data availability raise serious concern; the B6 count is inconsistent: table 1 88, table 3 df87, text t(88), PICO retained n89. The analysis included approximately 88–89 versus 87, with SD of baseline and final scores approximately 12.7–14.6; the authors report a detectable effect of 0.30 at 80% power. A between-group CI was not provided, and small effects cannot be ruled out with these data; p=0.140 does not prove equivalence. Independent replication of this exact outcome has not been established; publication bias remains unknown. This is an assessment of confidence in the comparative result, not of clinical significance or safety.
11 trialHigh-dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression ↗Young people in the anxiety study; analyzed B6 n=89, placebo n=87.
  1. High-dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression ↗
Nausea in pregnancyIn pregnant women before 17 weeks, nausea over 5 days fell by 2.9 out of 10 points with 30 mg pyridoxine daily and 2.0 points with placebo; difference in changes 0.9 points (p=0.0008).VAS decrease 2.9±2.2 versus 2.0±2.7 out of 10; difference 0.9; p=0.0008
3/4 ModerateConfidence is moderate: a randomised trial exists for the exact comparison. Random number table, identical placebo, double blinding; 336 of 342 were analysed, with 2 and 4 dropouts. Allocation concealment and registration are not fully established, but serious risk is not demonstrated by the available data. 336 analysed, change 2.9±2.2 versus 2.0±2.7 on a 10-cm scale. Given the moderate number and variability substantially exceeding the difference of 0.9, both a small and a more meaningful difference are possible; the comparative CI and patient-importance threshold were not reported. The downgrade is based on size and variability, not only p. Independent replication of this exact outcome has not been established; publication bias remains unknown. This is an assessment of confidence in the comparative result, not of clinical significance or safety.
11 trialPyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial ↗Pregnant women with nausea before 17 weeks; 342 randomized, 336 analyzed
  1. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial ↗

The study count refers to the cited source. Reviews with overlapping trials and outcomes from one study are not added together.

Daily intake requirements and upper limits

Intake and studied regimens
ContextInformation
Intake recommendationsUS total-intake recommendation: ages 19–50, 1.3 mg/day; after 50, 1.7 mg for men and 1.5 mg for women. Pregnancy 1.9 mg/day, breastfeeding 2.0 mg/day. These include food and supplements.

Vitamin B6 - Health Professional Fact Sheet ↗

Intake and studied regimens
ContextInformation
Intake and studied regimensThe studies described used 30–100 mg vitamin B6 daily. These doses exceed the EFSA upper level and describe research, not a self-directed regimen.

Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial ↗
Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial ↗
Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study ↗
High-dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression ↗
Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia: A randomized, single-blind clinical trial ↗
Scientific opinion on the tolerable upper intake level for vitamin B6 ↗

Forms

Vitamin B6 is a group of vitamers; pyridoxine is common in supplements. The name P5P does not establish superior efficacy or absence of neuropathy risk.

Guidance for each goal

Emotional PMS symptoms2/4 LowRead moreCollapse
Confidence
2/4 LowConfidence is low: a randomised trial exists for the exact comparison. Double-blind crossover RCT; 32 of 63 completed it, only 5 dropouts replied to the letter, and completers had more pronounced symptoms than those who completed 4–6 months. The substantial, potentially non-random loss creates serious uncertainty; the authors accounted for phase and for 5 partial completers separately. Only 32 completers, difference 2.97 with SE 1.37 on a 0–63 range; the relatively large error compared with the estimate leaves uncertainty about direction and magnitude on replication. The original CI was not provided; the clinical significance of the magnitude is unknown. Independent replication of this exact outcome has not been established; publication bias remains unknown. This is an assessment of confidence in the comparative result, not of clinical significance or safety.

For PMS, in 32 women who completed the crossover study, emotional symptoms with 50 mg pyridoxine daily were 2.97 study-scale points lower than with placebo after adjustment for phase (p<0.05).

Study findings. For PMS, in 32 women who completed the crossover study, emotional symptoms with 50 mg pyridoxine daily were 2.97 study-scale points lower than with placebo after adjustment for phase (p<0.05).

Studied regimen50 mg/dayOral pyridoxine
Duration and population3 menstrual cycles per regimenWomen aged 18–49 with moderate or marked premenstrual symptoms; 63 enrolled, 32 completed

Comparison: Placebo

Total anxiety score2/4 LowRead moreCollapse
Confidence
2/4 LowConfidence is low: a randomised trial exists for the exact comparison. Bottles were randomised by computer; they concealed the tablets, but the tablets differed in appearance. For a subjective outcome, possible unblinding and exclusions based on data availability raise serious concern; the B6 count is inconsistent: table 1 88, table 3 df87, text t(88), PICO retained n89. The analysis included approximately 88–89 versus 87, with SD of baseline and final scores approximately 12.7–14.6; the authors report a detectable effect of 0.30 at 80% power. A between-group CI was not provided, and small effects cannot be ruled out with these data; p=0.140 does not prove equivalence. Independent replication of this exact outcome has not been established; publication bias remains unknown. This is an assessment of confidence in the comparative result, not of clinical significance or safety.

In the high-dose B6 study, change in total anxiety score after about a month did not differ convincingly from placebo: time×group interaction p=0.140.

Study findings. In the high-dose B6 study, change in total anxiety score after about a month did not differ convincingly from placebo: time×group interaction p=0.140.

Studied regimen100 mg/dayOral pyridoxine
Duration and populationAbout 1 monthYoung people in the anxiety study; analyzed B6 n=89, placebo n=87.

Comparison: Placebo

Nausea in pregnancy3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateConfidence is moderate: a randomised trial exists for the exact comparison. Random number table, identical placebo, double blinding; 336 of 342 were analysed, with 2 and 4 dropouts. Allocation concealment and registration are not fully established, but serious risk is not demonstrated by the available data. 336 analysed, change 2.9±2.2 versus 2.0±2.7 on a 10-cm scale. Given the moderate number and variability substantially exceeding the difference of 0.9, both a small and a more meaningful difference are possible; the comparative CI and patient-importance threshold were not reported. The downgrade is based on size and variability, not only p. Independent replication of this exact outcome has not been established; publication bias remains unknown. This is an assessment of confidence in the comparative result, not of clinical significance or safety.

In pregnant women before 17 weeks, nausea over 5 days fell by 2.9 out of 10 points with 30 mg pyridoxine daily and 2.0 points with placebo; difference in changes 0.9 points (p=0.0008).

Study findings. In pregnant women before 17 weeks, nausea over 5 days fell by 2.9 out of 10 points with 30 mg pyridoxine daily and 2.0 points with placebo; difference in changes 0.9 points (p=0.0008).

Studied regimen10 mg every 8 hours, total 30 mg/dayOral pyridoxine hydrochloride
Duration and population5 daysPregnant women with nausea before 17 weeks; 342 randomized, 336 analyzed

Comparison: Placebo

Vomiting episodes in pregnancy3/4 ModerateRead moreCollapse
Confidence
3/4 ModerateConfidence is moderate: a randomised trial exists for the exact comparison. The same double-blind RCT methods and 6 dropouts out of 342; the analysis of episode counts was restricted to participants with vomiting at baseline. Selection by baseline status before treatment and relatively small attrition do not in themselves justify a serious downgrade. 112 versus 111, reduction of 1.22±2.0 versus 0.65±2.4 episodes per day: variability greatly exceeds the difference, and the range of plausible magnitudes includes important uncertainty about direction. p=0.0552 does not prove equivalence; no CI was provided. Independent replication of this exact outcome has not been established; publication bias remains unknown. This is an assessment of confidence in the comparative result, not of clinical significance or safety.

In the same study, vomiting episodes over 5 days decreased by 1.22 daily versus 0.65 with placebo; the difference in the period average was not statistically significant (p=0.0552).

Study findings. In the same study, vomiting episodes over 5 days decreased by 1.22 daily versus 0.65 with placebo; the difference in the period average was not statistically significant (p=0.0552).

Studied regimen30 mg/dayOral pyridoxine hydrochloride
Duration and population5 daysPregnant women vomiting at baseline; outcome table n=112 B6 and n=111 placebo

Comparison: Placebo

Vomiting after treatment2/4 LowRead moreCollapse
Confidence
2/4 LowConfidence is low: a randomised trial exists for the exact comparison. Double-blind RCT, but 59 of 74 completed it; reasons for dropout, distribution of dropouts and analysis of all randomised participants by group are unknown. Substantial attrition may change the observed comparison. Only the official abstract is available; the full article was not checked. 59 completers, 8/31 versus 15/28 with vomiting; few events and small groups permit a wide range of plausible magnitudes of the difference. No CI was provided or calculated. Independent replication of this exact outcome has not been established; publication bias remains unknown. This is an assessment of confidence in the comparative result, not of clinical significance or safety.

In the smaller pregnancy study, vomiting after three days occurred in 8 of 31 taking 75 mg pyridoxine daily and 15 of 28 on placebo.

Study findings. In the smaller pregnancy study, vomiting after three days occurred in 8 of 31 taking 75 mg pyridoxine daily and 15 of 28 on placebo.

Studied regimen25 mg every 8 hours, total 75 mg/dayOral pyridoxine
Duration and population3 daysPregnant women with nausea or vomiting; 74 randomized, 59 completed

Comparison: Placebo

Stress: whole group2/4 LowRead moreCollapse
Confidence
2/4 LowConfidence is low: a randomised trial exists for the exact comparison. Centralised randomisation and investigator blinding; participants were not blinded when self-assessing stress using DASS, which may systematically affect the result. Difference 0.72 points, 95% CI −1.15 to 2.59; the interval permits both a small advantage for magnesium and an advantage for the supplement of up to 2.59 points. Against the 42-point scale and without an established threshold, practical significance and the possibility of a moderate difference remain unresolved; zero alone is not grounds for a downgrade. Independent replication of this exact outcome has not been established; publication bias remains unknown. This is an assessment of confidence in the comparative result, not of clinical significance or safety.

In adults with stress and low magnesium, adding 30 mg B6 to 300 mg magnesium daily showed no convincing advantage at 8 weeks: stress-score improvement difference 0.72 points (95% CI −1.15…2.59).

Study findings. In adults with stress and low magnesium, adding 30 mg B6 to 300 mg magnesium daily showed no convincing advantage at 8 weeks: stress-score improvement difference 0.72 points (95% CI −1.15…2.59).

Studied regimen30 mg B6/day in the combinationMagnesium 300 mg elemental/day + pyridoxine 30 mg/day
Duration and population8 weeksHealthy adults with stress and suboptimal magnesium; mITT n=264

Comparison: Magnesium 300 mg/day without B6

Stress: high-stress subgroup2/4 LowRead moreCollapse
Confidence
2/4 LowConfidence is low: a randomised trial exists for the exact comparison. Unblinded participants assess subjective stress; the severe subgroup analysis was added after closure of the blinded database based on an observed interaction, and randomisation was not stratified by baseline stress severity. Together these constitute serious risk-of-bias concerns, not automatically two separate downgrades. Difference 3.16 points, 95% CI 0.50–5.82, n=162; the range spans a very small and a noticeably larger improvement on DASS, while the practical threshold is unknown. Excluding zero does not make the magnitude sufficiently precise. Independent replication of this exact outcome has not been established; publication bias remains unknown. This is an assessment of confidence in the comparative result, not of clinical significance or safety.

In the subgroup with high stress and low magnesium, magnesium plus B6 reduced stress score by 3.16 points more than magnesium alone over 8 weeks (95% CI 0.50–5.82).

Study findings. In the subgroup with high stress and low magnesium, magnesium plus B6 reduced stress score by 3.16 points more than magnesium alone over 8 weeks (95% CI 0.50–5.82).

Studied regimen30 mg B6/day in the combinationMagnesium 300 mg elemental/day + pyridoxine 30 mg/day
Duration and population8 weeksSubgroup of healthy adults with high stress and suboptimal magnesium; mITT n=162

Comparison: Magnesium 300 mg/day without B6

Safety and limitations

EFSA set an upper level for total B6 intake in adults, including pregnant and breastfeeding women, of 12 mg/day. The US uses 100 mg/day based on a different risk assessment. The upper level is not a target supplement dose. B6 supplements may be linked to peripheral neuropathy: tingling, burning or numbness. TGA recorded cases even below 50 mg/day, especially with multiple B6 products; frequency and personal thresholds cannot be determined from reports. Stop the suspected supplement and seek professional advice if tingling, burning or numbness occurs. The nausea result concerns pregnant women before 17 weeks and short five-day use of 30 mg/day; it does not extend to other stages or long-term use. EFSA total vitamin B6 upper levels: ages 4–6 months, 2.2 mg/day; 7–11 months, 2.5 mg/day; 1–3 years, 3.2 mg/day; 4–6 years, 4.5 mg/day; 7–10 years, 6.1 mg/day; 11–14 years, 8.6 mg/day; 15–17 years, 10.7 mg/day. These are limits from all sources, not supplement doses.

Scientific opinion on the tolerable upper intake level for vitamin B6 ↗ · Vitamin B6 - Health Professional Fact Sheet ↗ · Peripheral neuropathy with supplementary vitamin B6 (pyridoxine) ↗ · Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial ↗

Interactions

WithEffectActionSource
CycloserineMay increase urinary vitamin B6 loss; low B6 status is linked to neurological adverse-effect risk from the medicine.Discuss vitamin B6 with your treating doctor if taking cycloserine.Vitamin B6 - Health Professional Fact Sheet ↗
Valproic acid, carbamazepine and phenytoinMay increase breakdown of B6 vitamers and lower blood PLP.Discuss vitamin B6 status and all supplements with your doctor.Vitamin B6 - Health Professional Fact Sheet ↗
Phenytoin and phenobarbitalIn some studies, pyridoxine at 200 mg/day for 12–120 days lowered phenytoin and phenobarbital concentrations; effects of lower doses are unknown.Discuss dose and treatment monitoring with your doctor before taking B6.Vitamin B6 - Health Professional Fact Sheet ↗
TheophyllineLow PLP is often found in people taking theophylline and may be linked to neurological adverse effects.Discuss B6 status and your supplements with your doctor.Vitamin B6 - Health Professional Fact Sheet ↗

Food sources

The table shows vitamin B6 content in the specified foods and states, not absorbed vitamin. USDA data are from the 2015 release; the stated portion weights were selected for comparison.

Fish and seafood

Vitamin B6 occurs in fish, including tuna and salmon.

Vitamin B6 - Health Professional Fact Sheet ↗

Meat and poultry

Sources include poultry, meat and liver.

Vitamin B6 - Health Professional Fact Sheet ↗

Legumes, starchy vegetables and fruit

B6 comes from chickpeas, potatoes and some fruit.

Vitamin B6 - Health Professional Fact Sheet ↗

Fortified cereals and other foods

Some cereals are fortified with vitamin B6; check the label.

Vitamin B6 - Health Professional Fact Sheet ↗

Food composition

FoodGroupAmountServingCaloriesSources
Chickpeascanned, mature seeds and liquidLegumes0.473 mg vitamin B6 / 100 g240 g · 1.1352 mg vitamin B6 · 211.2 kcal1 cup; weight from USDA.88 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — Legumes and Legume Products ↗
Beef liverbraised, edible portionMeat and offal1.017 mg vitamin B6 / 100 g85 g · 0.86445 mg vitamin B6 · 162.35 kcalEdible-portion weight selected for comparison; content and energy calculated from USDA data.191 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — Beef Products ↗
Yellowfin tunafresh, cooked with dry heatFish1.038 mg vitamin B6 / 100 g85 g · 0.8823 mg vitamin B6 · 110.5 kcal3 ounces edible portion; weight from USDA.130 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — Finfish and Shellfish Products ↗
Sockeye salmoncooked with dry heatFish0.827 mg vitamin B6 / 100 g85 g · 0.70295 mg vitamin B6 · 132.6 kcalEdible-portion weight selected for comparison; content and energy calculated from USDA data.156 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — Finfish and Shellfish Products ↗
Pork tenderloinroasted, separable lean meatMeat and offal0.739 mg vitamin B6 / 100 g85 g · 0.62815 mg vitamin B6 · 121.55 kcalEdible-portion weight selected for comparison; content and energy calculated from USDA data.143 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — Pork Products ↗
Lentilsmature seeds, boiled, unsaltedLegumes0.178 mg vitamin B6 / 100 g100 g · 0.178 mg vitamin B6 · 116 kcalEdible-portion weight selected for comparison; content and energy calculated from USDA data.116 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — Legumes and Legume Products ↗
Sunflower seedsdry-roasted kernels, unsaltedSeeds0.804 mg vitamin B6 / 100 g30 g · 0.2412 mg vitamin B6 · 174.6 kcalEdible-portion weight selected for comparison; content and energy calculated from USDA data.582 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — Nut and Seed Products ↗
Bananaraw, edible portionFruit0.367 mg vitamin B6 / 100 g100 g · 0.367 mg vitamin B6 · 89 kcalEdible-portion weight selected for comparison; content and energy calculated from USDA data.89 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — Fruits and Fruit Juices ↗
GENERAL MILLS TOTAL Raisin Bran cerealfortified, dry, ready to eatCereals3.774 mg vitamin B6 / 100 g30 g · 1.1322 mg vitamin B6 · 93.6 kcalEdible-portion weight selected for comparison; content and energy calculated from USDA data.312 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — Breakfast Cereals ↗
Hen's eggwhole, hard-boiled, edible portionEggs0.121 mg vitamin B6 / 100 g50 g · 0.0605 mg vitamin B6 · 77.5 kcalEdible-portion weight selected for comparison; content and energy calculated from USDA data.155 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — Dairy and Egg Products ↗
Milknonfat fluid, with added vitamins A and DDairy products0.037 mg vitamin B6 / 100 g200 g · 0.074 mg vitamin B6 · 68 kcalEdible-portion weight selected for comparison; content and energy calculated from USDA data.34 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — Dairy and Egg Products ↗

Studies

PublicationWhat was studiedParticipantsForm and doseResult
Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial ↗Emotional PMS symptomsWomen aged 18–49 with moderate or marked premenstrual symptoms; 63 enrolled, 32 completedOral pyridoxine; 50 mg/day; 3 menstrual cycles per regimen; comparison: PlaceboFor PMS, in 32 women who completed the crossover study, emotional symptoms with 50 mg pyridoxine daily were 2.97 study-scale points lower than with placebo after adjustment for phase (p<0.05).
High-dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression ↗Total anxiety scoreYoung people in the anxiety study; analyzed B6 n=89, placebo n=87.Oral pyridoxine; 100 mg/day; About 1 month; comparison: PlaceboIn the high-dose B6 study, change in total anxiety score after about a month did not differ convincingly from placebo: time×group interaction p=0.140.

Sources

Sources
  1. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial ↗
  2. High-dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression ↗
  3. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial ↗
  4. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study ↗
  5. Superiority of magnesium and vitamin B6 over magnesium alone on severe stress in healthy adults with low magnesemia: A randomized, single-blind clinical trial ↗
  6. Vitamin B6 - Health Professional Fact Sheet ↗
  7. Scientific opinion on the tolerable upper intake level for vitamin B6 ↗
  8. Peripheral neuropathy with supplementary vitamin B6 (pyridoxine) ↗
  9. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial ↗
  10. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — Dairy and Egg Products ↗
  11. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — Breakfast Cereals ↗
  12. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — Fruits and Fruit Juices ↗
  13. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — Pork Products ↗
  14. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — Nut and Seed Products ↗
  15. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — Beef Products ↗
  16. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — Finfish and Shellfish Products ↗
  17. USDA National Nutrient Database for Standard Reference, Release 28 (2015) — Legumes and Legume Products ↗